Skip to main content
. 2020 Feb 10;13(6):1025–1036. doi: 10.1093/ckj/sfz176

Table 3.

List of mutations found in patients who reached ESKD

Patient Article Age at ESRD (years) Mutated gene cDNA position Protein position HGMD
1 Jefferson et al. [24] 35 COL4A3 c.4421T>Ca p.Leu1474Pro CM1310319
2 van der Loop et al. [25] 35 COL4A3 c. 1315G>Ab (leading to exon 21 skipping) p.Gly439Serb (including exon 21 skipping) CS003734
3 Ciccarese et al. [26] 60 COL4A4 c.975G>T p.Lys325Asn CM014171
4 Ciccarese et al. [26] 66 COL4A4 c.975G>T p.Lys325Asn CM014171
5 Pescucci et al. [27] 41 COL4A4 c.2869G>C p.Gly957Arg CM044600
6 Pescucci et al. [27] 52 COL4A4 c.2869G>C p.Gly957Arg CM044600
7 Pescucci et al. [27] 84 COL4A3 c.3134G>T p.Gly1045Val CM044599
8 Pescucci et al. [27] 45 COL4A3 c.3655G>T p.Gly1219Cys CM044598
9 Pescucci et al. [27] 70 COL4A3 c.3655G>T p.Gly1219Cys CM044598
10 Marcocci et al. [28] 46 COL4A4 c.1580delG or c.1580_1580delG p.Gly527Valfs*126 CD095038
11 Marcocci et al. [28] 67 COL4A4 c.1580delG or c.1580_1580delG p.Gly527Valfs*126 CD095038
12 Marcocci et al. [28] 42 COL4A4 c.4494delG or c.4494_4494delG p.Gln1499Lysfs*53 CD095039
13 Marcocci et al. [28] 60 COL4A4 c.2383 + 2T>G (ivs28 + 2T>G) NA (splicing mutation) CS095029
14 Marcocci et al. [28] 45 COL4A4 c.3289 + 1G>A (ivs35 + 1G>A) NA (splicing mutation) CS073457
15 Marcocci et al. [28] 60 COL4A4 c.3289 + 1G>A (ivs35 + 1G>A) NA (splicing mutation) CS073457
16 Pierides et al. [3] 57 COL4A3 c.4001G>A p.Gly1334Glu CM014047
17 Pierides et al. [3] 64 COL4A3 c.4001G>A p.Gly1334Glu CM014047
18 Pierides et al. [3] 58 COL4A3 c.4001G>A p.Gly1334Glu CM014047
19 Pierides et al. [3] 68 COL4A3 c.4001G>A p.Gly1334Glu CM014047
20 Pierides et al. [3] 55 COL4A3 c.4001G>A p.Gly1334Glu CM014047
21 Pierides et al. [3] 53 COL4A4 c.3648delG (previously mentioned 3854delG) p.Ser1217Alafs*71 CD982552
22 Pierides et al. [3] 40 COL4A4 c.3648delG (previously mentioned 3854delG) p.Ser1217Alafs*71 CD982552
23 Pierides et al. [3] 67 COL4A3 c.4001G>A p.Gly1334Glu CM014047
24 Pierides et al. [3] 78 COL4A3 c.4001G>A p.Gly1334Glu CM014047
25 Pierides et al. [3] 62 COL4A3 c.4001G>A p.Gly1334Glu CM014047
26 Pierides et al. [3] 52 COL4A3 c.2611G>T p.Gly871Cys CM077179
27 Pierides et al. [3] 62 COL4A3 c.4001G>A p.Gly1334Glu CM014047
28 Pierides et al. [3] 45 COL4A3 c.4001G>A p.Gly1334Glu CM014047
29 Pierides et al. [3] 83 COL4A3 c.4001G>A p.Gly1334Glu CM014047
30 Pierides et al. [3] 55 COL4A3 c.4001G>A p.Gly1334Glu CM014047
31 Pierides et al. [3] 55 COL4A3 c.4001G>A p.Gly1334Glu CM014047
32 Pierides et al. [3] 65 COL4A3 c.2611G>T p.Gly871Cys CM077179
33 Artuso et al. [29] 24 COL4A4 c.4749_4751delGTC c.5044C>T p.(Gln1583_Ser1584delinsHis) p.Arg1682Trpc CD120076 CM120075
34 Fallerini et al. [30] 70 COL4A3 c.2083G>A p.Gly695Arg CM040407
35 Fallerini et al. [30] 72 COL4A3 c.3239G>C p.Gly1080Ala CM148115
36 Fallerini et al. [30] 60 COL4A4 c.217C>T p.Gln73* CM148117
37 Fallerini et al. [30] 43 COL4A4 c.1109G>A p.Gly370Glu CM148118
38 Fallerini et al. [30] 53 COL4A4 c.1109G>A p.Gly370Glu CM148118
39 Fallerini et al. [30] 59 COL4A4 c.1109G>A p.Gly370Glu CM148118
40 Fallerini et al. [30] 54 COL4A4 c.2752G>A p.Gly918Arg CM148122
41 Fallerini et al. [30] 38 COL4A4 c.4444delC p.Leu1482Trpfs*70 CD148126
42 Fallerini et al. [30] 52 COL4A4 c.4749_4751delGTC p.Gln1583_Ser1584delinsHis
43 Papazachariou et al. [31] 37 COL4A4 c.3648delG p.Ser1217Alafs*71 CD982552
44 Papazachariou et al. [31] 69 COL4A3 c.4001G>A p.Gly1334Glu CM014047
45 Papazachariou et al. [31] 45 COL4A3 c.4001G>A p.Gly1334Glu CM014047
46 Papazachariou et al. [31] 39 COL4A3 c.4001G>A p.Gly1334Glu CM014047
47 Papazachariou et al. [31] 55 COL4A3 c.4001G>A p.Gly1334Glu CM014047
48 Papazachariou et al. [31] 40 COL4A3 c.4001G>A p.Gly1334Glu CM014047
49 Papazachariou et al. [31] 51 COL4A3 c.1450G>A p.Gly484Arg CM1413855
50 Papazachariou et al. [31] 55 COL4A3 c.1450G>A p.Gly484Arg CM1413855
51 Papazachariou et al. [31] 69 COL4A4 c.428G>T p.Gly143Val CM1413857
52 Papazachariou et al. [31] 43 COL4A4 c.623G>A pGly208Asp CM1413858
53 Lin et al. [32] 63 COL4A4 c.G2636A (;) c.C4715T p.Gly879Glu(;) p.Pro1572Leu CM1412497(;) CM980400
54 Lin et al. [32] 55 COL4A4 c.2990G>Ad p.Gly997Glu NA
55 Ramzan et al. [33] 55 COL4A4 c.2420delG p.Gly807Valfs*62 CD1313492
56 Rosado et al. [34] 22 COL4A3 c.345delG p.Pro116Leufs*37 CD150451
57 Rosado et al. [34] 31 COL4A3 c.4235G>T p.Gly1412Val CM034407
58 Rosado et al. [34] 34 COL4A3 c.4235G>T p.Gly1412Val CM034407
59 Kamiyoshi et al. [20] 63 COL4A4 c.1733G>T p.Gly578Val CM143835
60 Deng et al. [35] 56 COL4A4 c.3213delA or c.3213_3213delA p.Gly1072Glufs*69 CD1617449
61 Deng et al. [35] 60 COL4A4 c.3213delA or c.3213_3213delA p.Gly1072Glufs*69 CD1617449
62 Papazachariou et al. [14] 55 COL4A3 c.3751G>A p.Gly1251Ser CM1714507
63 Papazachariou et al. [14] 61 COL4A3 c.3751G>A p.Gly1251Ser CM1714507
64 Papazachariou et al. [14] 65 COL4A3 c.3751G>A p.Gly1251Ser CM1714507
65 Papazachariou et al. [14] 23 COL4A4 c.2242G>A p.Gly748Ser CM1714512
66 Papazachariou et al. [14] 63 COL4A4 c.489 + 1G>C (ivs7 + 1G>C) NA (splicing mutation) CS1714514
67 Imafuku et al. [36] 60 COL4A4 c.1323_1340del18bp p.(Pro444_Leu449del)e CD982550
68 Imafuku et al. [36] 58 COL4A4 c.827G>C p.Gly276Ala CM1720200
69 Imafuku et al. [36] 42 COL4A3 c.2863G>A p.Gly955Arg CM1720204
70 Bullich et al. [22] 21 COL4A3 c.2125 + 1_2224-1)_(2980 + 1_3071-1)dup Duplication of ex. 29-30_36 CN1811341
71 Bullich et al. [22] 42 COL4A3 c.2275G>A p.Gly759Arg CM1811343
72 Bullich et al. [22] 56 COL4A4 c.1460G>T p.Gly487Val CM1414118
73 Bullich et al. [22] 40 COL4A4 c.4508delA or c.4508_4508delA p.His1503Profs*49 CD1811330
74 Bullich et al. [22] 41 COL4A4 c.3817G>A p.Gly1273Arg CM1811348
75 Kharrat et al. [37] 40 COL4A3 or COL4A4f ND ND ND
76 Kharrat et al. [37] 53 COL4A3 or COL4A4f ND ND ND
a

HGMD, Human Gene Mutation Database. In the original publication by Jefferson et al. [24], this mutation is referred to as p.Leu36Pro, as the counting in those days, was from the 3′-end of the gene and was corresponding to exon 5.

b

Described as p.Gly493Ser, which leads to a splicing mutation, skipping of exon 21, 55aa, from 439 to 493 (also coded as p.439. aGGT>AGT, Gly439Ser. A mutated chain that lacks 55 amino acids in the collagenous domain, between Gly438 and Gly493).

c

Glutamine and serine are deleted, and histidine is inserted.

d

In the original publication, it was erroneously referred to as c.Gly2290Ala.

e

Deletion of six amino acids (Gly-Lys-Pro-Gly-Ala-Pro) from Gly442 to Pro448.

f

Pathogenicity was defined by linkage analysis, specific gene not defined (ND), NA, not applicable.